Cite

HARVARD Citation

    Cromer, D. et al. (2022). Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial. Clinical infectious diseases. pp. e878-e879. [Online]. 
  
Back to record